Neurology in Maryland

Restorative Therapies, Inc. is a leading B2B manufacturer of integrated Functional Electrical Stimulation (FES) therapy systems for neurorehabilitation. Founded in 2004 and headquartered in Nottingham, Maryland, the company specializes in advanced FES technology designed for both clinical and home-based rehabilitation settings. The company serves over 1,000 clinics and 4,000 home patients across 20+ countries, with a clinical footprint spanning spinal cord injury, stroke, cerebral palsy, traumatic brain injury, and multiple sclerosis. Restorative Therapies' integrated FES systems use controlled electrical impulses to activate weak or paralyzed muscles, promoting coordinated muscle contractions that facilitate neuroplasticity, improve gait training, reduce secondary complications, and restore functional mobility. The company provides comprehensive clinical training, customized therapeutic solutions, and seamless clinic-to-home transition support. Notable partnerships include the Christopher and Dana Reeve Foundation and dedicated programs for veterans and small businesses.

Limber Health is a digital health platform serving physical and occupational therapy organizations. The company provides a comprehensive, cloud-based solution designed to extend in-person rehabilitation care into the home environment through Remote Therapeutic Monitoring (RTM), digital home exercise programs (HEP), patient-reported outcomes (PROs) collection, and value-based care support. The platform features a library of over 7,000 professionally produced exercise videos spanning multiple specialties: musculoskeletal and orthopedic therapy, vestibular rehabilitation, hand therapy, pediatrics, neurology, pelvic health, craniomandibular/TMJ, and orofacial therapy. Limber offers 100+ pre-built clinical protocols for non-surgical conditions, surgical procedures, and orthobiologic interventions. The platform includes integrated MIPS reporting and CMS-approved Qualified Clinical Data Registry (QCDR) functionality to support value-based care and compliance. Key features include real-time data analytics, patient adherence tracking, automated outcomes collection, care navigation with licensed therapy professionals, and seamless EMR integration. Clinically validated through research at Mayo Clinic, the platform is designed to improve patient engagement, outcomes, and operational efficiency while reducing administrative burden for therapy practices. Trusted by leading rehabilitation networks and independent practices across the United States.

BrainScope is a commercial-stage medical neurotechnology company specializing in AI-powered EEG-based diagnostic solutions for brain health. Founded in 2006 and based in Rockville, Maryland, BrainScope has developed a proprietary platform that applies machine learning and computational neuroscience to transform brain electrical activity (EEG) into objective clinical biomarkers. The company created the first FDA-cleared AI/Machine Learning medical device in neurology and holds a portfolio of 83 issued patents. BrainScope's primary offering is a hand-held, point-of-care device for assessing mild traumatic brain injuries (mTBI), structural brain bleeds, and concussions in under 20 minutes. The technology has demonstrated ~50% reduction in unnecessary head CT scans and substantial reductions in emergency department patient length of stay. Beyond head injury assessment, BrainScope is developing novel biomarkers for stroke detection, early Alzheimer's detection (with dementia risk prediction up to 7 years before initial diagnosis), and other CNS indications. The company serves acute care settings, hospitals, emergency departments, and pharmaceutical/drug development partners.

Longeviti Neuro Solutions designs and manufactures innovative implantable platforms for complex brain surgery. The company's flagship product line includes ClearFit® patient-specific and off-the-shelf cranial implants that enable real-time ultrasound imaging post-operatively, reducing patient radiation exposure while supporting bedside or clinic-based monitoring. ClearFit® implants are FDA-cleared and designed to correct and restore bony voids and cranial defects while maintaining compatibility with ultrasound visualization. Longeviti also manufactures InvisiShunt® and InvisiLead, low-profile cranial implants that integrate with the skull's natural contour while accommodating neurosurgical devices such as shunts and leads. The company partners with Clarius Mobile Health and GE Healthcare to integrate handheld and console-based ultrasound systems into its clinical workflow. Founded by leading neurosurgeons, medical device executives, and biomedical engineers, Longeviti focuses on restoring patients to anatomical and neurological normalcy through innovative functional neurotechnology. Products are sterilized, come in multiple sizes and curvatures, and are intended for use in neurosurgical departments, operating rooms, and post-operative monitoring environments. The company provides medical education resources and clinical support to healthcare providers.

EpiWatch is an FDA-cleared, prescription-based mobile health platform that delivers real-time tonic-clonic seizure detection and alerting via Apple Watch and iPhone. The AI-powered application runs passively on wearable devices to monitor seizure activity and provides immediate alerts to caregivers when critical events occur, enabling rapid intervention and reducing the risk of Sudden Unexpected Nocturnal Death in Epilepsy (SUDEP). Designed for both pediatric and adult patients with epilepsy, EpiWatch integrates with family sharing and caregiver contact systems, requiring cellular or Wi-Fi connectivity for continuous monitoring. Available by prescription only in the United States at a monthly subscription fee, the platform empowers patients with independence while providing caregivers actionable intelligence during life-threatening events.

UprightVR Inc. develops an FDA-registered, immersive virtual reality system for balance assessment, rehabilitation, and fall prevention. The platform combines VR technology with neuroscience-based diagnostics to measure sensory-motor integration and vestibular function in 8 minutes, generating detailed clinical and patient reports. Primary markets include physical therapy clinics, senior living communities, rehabilitation hospitals, and medical practices. The system includes RecoVR™ therapeutic rehabilitation modules—gamified exercises designed for patients with concussions, strokes, balance disorders, Parkinson's disease, cerebellar ataxia, hearing and balance impairments, and post-injury recovery. Assessment tools include SafetyNet™ for detecting hidden balance deficits and VOR (vestibular ocular reflex) retraining games. The company emphasizes portable, affordable deployment requiring minimal space and setup. Revenue model targets higher insurance reimbursement rates for advanced balance assessment and therapy. Developed by Geoffrey Wright, Ph.D., Professor of Neuromotor Sciences at Temple University, with two decades of clinical research validation across diverse patient populations. Offers comprehensive customer support including onboarding, remote and on-site training, clinical consultations, and data analytics. Continuous software updates add new assessments and rehabilitation modules.